$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2015 Q4 Form 10-K Financial Statement

#000114420416094382 Filed on April 14, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00K $30.00K $10.00K
YoY Change 0.0% -25.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.00K $30.92K $10.00K
YoY Change 0.0% -15.73%
Operating Profit -$30.92K
YoY Change -13.92%
Interest Expense $14.02K
YoY Change 4147.88%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$10.00K -$30.92K -$10.00K
YoY Change 0.0% -14.7%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$20.00K -$62.86K -$10.00K
YoY Change 100.0% 73.44%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.945K -$0.02 -$1.972K
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $1.840K $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables
Total Short-Term Assets $1.838K $1.840K $205.00
YoY Change 796.59% -60.95%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.838K $1.840K $205.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.838K $1.840K $205.00
YoY Change 796.59% -60.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.86K $10.86K $9.966K
YoY Change 8.94% 8.6%
Accrued Expenses $0.00 $3.000K
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.33K $83.33K $35.59K
YoY Change 134.11% 108.33% 15.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.33K $83.33K $35.59K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $83.33K $83.33K $35.59K
YoY Change 134.11% 108.33% 15.5%
SHAREHOLDERS EQUITY
Retained Earnings -$180.0K -$117.2K
YoY Change 53.64%
Common Stock $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$81.49K -$81.49K -$35.39K
YoY Change
Total Liabilities & Shareholders Equity $1.838K $1.840K $205.00
YoY Change 796.59% -60.95%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$20.00K -$62.86K -$10.00K
YoY Change 100.0% 73.44%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $10.00K -$30.23K -$10.00K
YoY Change -200.0% 0.77% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K 30.02K 10.00K
YoY Change -200.0% 0.07%
NET CHANGE
Cash From Operating Activities 10.00K -30.23K -10.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities -10.00K 30.02K 10.00K
Net Change In Cash 0.000 -210.0 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities $10.00K -$30.23K -$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49587 USD
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
742 USD
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
773 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36687 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
49587 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
36687 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-48845 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-35914 USD
CY2015 us-gaap Interest Expense
InterestExpense
14018 USD
CY2014 us-gaap Interest Expense
InterestExpense
330 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-62863 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-36244 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-62863 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-36244 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2015 us-gaap Accretion Of Discount
AccretionOfDiscount
13619 USD
CY2014 us-gaap Accretion Of Discount
AccretionOfDiscount
330 USD
CY2015Q4 us-gaap Cash
Cash
1838 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
1838 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
205 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3693 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12966 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-45151 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-26173 USD
CY2015Q4 us-gaap Assets
Assets
1838 USD
CY2014Q4 us-gaap Assets
Assets
205 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
0 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30024 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22628 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
16760 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3225 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16659 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9966 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 USD
CY2015Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
52652 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22628 USD
CY2015Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
13619 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
46784 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25853 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83330 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35594 USD
CY2015Q4 us-gaap Liabilities
Liabilities
83330 USD
CY2014Q4 us-gaap Liabilities
Liabilities
35594 USD
CY2015 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 us-gaap Interest Paid
InterestPaid
0 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
1633 USD
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-320 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
93483 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180048 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117185 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-81492 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-35389 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1838 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205 USD
CY2015 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
0 USD
CY2014 osok Noncash Investing And Financing Items Gain On Forgiveness Of Related Party Notes Payable
NoncashInvestingAndFinancingItemsGainOnForgivenessOfRelatedPartyNotesPayable
28146 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
86391 USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2014 us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
26695 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-26695 USD
CY2015 osok Effective Income Tax Rate Reconciliation Operating Loss
EffectiveIncomeTaxRateReconciliationOperatingLoss
0.39 pure
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
45702 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
86391 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45702 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Notes Payable
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyNotesPayable
27921 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3225 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
16760 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14135 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-14135 USD
CY2015 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
0 USD
CY2014 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
0 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2014 osok Effective Income Tax Rate Reconciliation Operating Loss
EffectiveIncomeTaxRateReconciliationOperatingLoss
0.39 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
0 USD
CY2014Q4 osok Related Party Forgiveness Of Note Payable Convertible Note Payable And Accrued Interest
RelatedPartyForgivenessOfNotePayableConvertibleNotePayableAndAccruedInterest
27921 USD
CY2015 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0 shares
CY2015 dei Document Type
DocumentType
10-K
CY2015 dei Amendment Flag
AmendmentFlag
false
CY2015 dei Document Period End Date
DocumentPeriodEndDate
2015-12-31
CY2015 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015 dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
CY2015 dei Entity Central Index Key
EntityCentralIndexKey
0001500198
CY2015 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Entity Public Float
EntityPublicFloat
315115 USD
CY2015 dei Trading Symbol
TradingSymbol
OSOK
CY2016Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30291 USD
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Products and services, geographic areas and major customers</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
52652 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
22628 USD
CY2015 osok Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
400 USD
CY2014 osok Increase Decrease In Accrued Liabilities Related Parties
IncreaseDecreaseInAccruedLiabilitiesRelatedParties
-3225 USD
CY2015Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
400 USD
CY2014Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
0 USD

Files In Submission

Name View Source Status
0001144204-16-094382-index-headers.html Edgar Link pending
0001144204-16-094382-index.html Edgar Link pending
0001144204-16-094382.txt Edgar Link pending
0001144204-16-094382-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
osok-20151231.xml Edgar Link completed
osok-20151231.xsd Edgar Link pending
osok-20151231_cal.xml Edgar Link unprocessable
osok-20151231_def.xml Edgar Link unprocessable
osok-20151231_lab.xml Edgar Link unprocessable
osok-20151231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v435285_10k.htm Edgar Link pending
v435285_31.htm Edgar Link pending
v435285_32.htm Edgar Link pending